Ayurvedic Bhasmas: Overview on Nanomaterialistic Aspects, Applications, and Perspectives

  • Rameshwar AdhikariEmail author
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 807)


In this paper, we present an overview of Ayurvedic Bhasmas as nanomedicine of herbo-metallic and mineral origin with particular attention to their structural aspects. We find, the Bhasmas as nanomedicines may offer a huge potential for designing new drugs employing the concept of nanotechnology. Thus, the standardization of fabrication process of these formulations is a crucial issue to be addressed. The structure and effectiveness of the Bhasmas as drugs depend largely on their processing history. Bhasmas are generally safe drugs for human beings in spite of the presence of seemingly toxic elements and compounds as indicated by recent studies using modern analytical techniques. Nevertheless, more systematic nanomaterialistic investigations on Bhasmas are recommended for gaining the complete and reliable composition-processing-structure-effectiveness picture of these drugs.


Ayurveda Bhasma Nanomedicine Heavy metal toxicity 



The author would like to thank Alexander von Humboldt Foundation for supporting his several research stays in Germany which triggered his interest in Ayurvedic medicines, in particular with Bhasmas. Dr. Surendra Kumar Gautam (Department of Chemistry, Tribhuvan University, Tri-Chandra Campus, Kathmandu) is thanked for critically reading the manuscript.


  1. 1.
    Krishnamachary B, Rajendran N, Pemiah B, Krishnaswamy S, Krishnan UM, Swaminathan Sethuraman S, Sekar RK (2012) Scientific validation of the different purification steps involved in the preparation of an Indian ayurvedic medicine, Lauha Bhasma. J Ethnopharmacol 142:98–104CrossRefGoogle Scholar
  2. 2.
    Bhatia BS, Kale PG, Daoo JV, Panchal PP (2012) Abhraka Bhasma treatment ameliorates proliferation of germinal epithelium after heat exposure in rats. Anc Sci Life 31:171–180CrossRefGoogle Scholar
  3. 3.
    Sarkar PK, Das S, Prajapati PK (2010) Ancient concept of metal pharmacology based on ayurvedic literature. Ancient Sci Life 29:1–6Google Scholar
  4. 4.
    Jagtap CY, Prajapati P, Patgiri B, Shukla VJ (2012) Quality control parameters for Tamra (copper) Bhasma. Anc Sci Life 31:64–170Google Scholar
  5. 5.
    Wadekar MP, Rode CV, Bendale YN, Patil KR, Prabhune AA (2005) Preparation and characterization of a copper based Indian traditional drug: Tamra Bhasma. J Pharmac Biomed Anal 39:951–955CrossRefGoogle Scholar
  6. 6.
    Unni K, Sheela KB, Vijasankar AV (2013) Scientific basis for the preparation and characterization of iron based traditional drug Annabhedi Sinduram: a materialistic approach. Int Res J Ayurveda Pharm 4:149–152Google Scholar
  7. 7.
    Mulik SK, Jha CB (2011) Physicochemical characterization of an Iron based Indian traditional medicine: Mandura Bhasma. Ancient Sci Life 31:52–57Google Scholar
  8. 8.
    Krishnamachary B, Purushothaman AK, Pemiah B, Krishnaswamy S, Krishnan UM, Sethuraman S, and Sekar RK (2013) Bhanupaka: a green process in the preparation of an Indian ayurvedic medicine, Lauha Bhasma. J Chem 951951Google Scholar
  9. 9.
    Patwardhan B, Mashelkar RA (2009) Traditional medicine-inspired approaches to drug discovery: can ayurveda show the way forward? Drug Disc Today 14:804–811CrossRefGoogle Scholar
  10. 10.
    Chaudhary A (2011) Ayurvedic Bhasma: nanomedicine of ancient India—its global contemporary perspective. J Biomed Nanotech 7:68–69CrossRefGoogle Scholar
  11. 11.
    Paul W, Sharma CP (2011) Blood compatibility studies of Swarna Bhasma (Gold Bhasma), an ayurvedic drug. Int J Ayurveda Res 2:14–22Google Scholar
  12. 12.
    Kumar G, Srivastava A, Sharma SK, Gupta YK (2012) Safety evaluation of an ayurvedic medicine, Arogyavardhini vati on brain, liver and kidney in rats. J Ethnopharmacol 140:151–160CrossRefGoogle Scholar
  13. 13.
    Paul S, Chugh A (2011) Accessing the role of ayurvedic bhasmas as ethono-nanomedicine in the metal based nanomedicine patent regime. J Intell Prop Rights 16:509–515Google Scholar
  14. 14.
    Khan MS, Vishakante GD, Siddaramaiah H (2013) Gold nanoparticles: a paradigm shift in biomedical applications. Adv Colloid Interf Sci 199–200:44–58CrossRefGoogle Scholar
  15. 15.
    Dobrovolskaia MA, McNeil SE (2007) Immunological properties of engineered nanomaterials. Nat Nanotechnol 2:469–478CrossRefGoogle Scholar
  16. 16.
    Bhattacharya B (2011) Elucidating the nanomaterialistic basis for Ayurvedic Bhasmas using physicochemical experimentation. J Biomed Nanotech 7(2011):66–67CrossRefGoogle Scholar
  17. 17.
    Virupaksha Gupta KL, Kumar N (2012) Characterization of Tarakeshwara Rasa: an ayurvedic herbomineral formulation. Ayurveda 33:406–411Google Scholar
  18. 18.
    Patra CR, Bhattacharya R, Mukhopadhyay D, Mukherjee P (2010) Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev 62:346–361CrossRefGoogle Scholar
  19. 19.
    Mohaptra S, Jha CB (2010) Physicochemical characterization of Ayurvedic bhasma (Swarna Makshika Bhasma): an approach to standardization. Int J Ayurveda 1:82–86Google Scholar
  20. 20.
    Singh N, Reddy KRC (2010) Pharmaceutical study of Lauha Bhasma. Ayurveda 31:387–390Google Scholar
  21. 21.
    Panyala NR, Peña-Méndez EM, Havel J (2009) Gold and nano-gold in medicine: overview, toxicology and perspectives. J Appl Biomed 7:75–91Google Scholar

Copyright information

© Springer India 2014

Authors and Affiliations

  1. 1.Central Department of ChemistryTribhuvan UniversityKirtipur, KathmanduNepal
  2. 2.Nepal Polymer InstituteKathmanduNepal

Personalised recommendations